Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px

News > All

Total search results: 9811 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 97 98 99  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Divide & Conquer. (9/18/19). "Press Release: Divide & Conquer, Developing New Class of Cancer Therapeutics to Disrupt Cell-to-Cell Communication, Emerges from Stealth as New Paper by Co-Founder is Published in Nature". Cambridge. 2019-09-18
Themis Bioscience GmbH. (9/18/19). "Press Release: Themis Raises EUR 40 Million in Series D Financing Round Backed by US/EU Consortium to Support Pivotal Study and Expand Clinical Pipeline". Vienna. 2019-09-18
Roche. (9/18/19). "Press Release: FDA Grants Breakthrough Therapy Designation for Roche’s Gazyva (obinutuzumab) in Lupus Nephritis". Basel. 2019-09-18
AC Immune S.A.. (9/17/19). "Press Release: AC Immune Receives Milestone Payment in Connection with Initiation of a Phase 2 Trial of Tau PET Tracer PI-2620". Lausanne. 2019-09-17
CRISPR Therapeutics AG. (9/17/19). "Press Release: CRISPR Therapeutics and ViaCyte Present Positive In Vitro Data Towards a Potential Immune-Evasive Cell Replacement Therapy for Diabetes at EASD 2019". Zug, Cambridge, MA & San Diego, CA. 2019-09-17
Bayer AG. (9/17/19). "Press Release: Bayer and Informed Data Systems Inc. to Develop One Drop Digital Therapeutics Platform for Multiple Therapeutic Areas [Not intended for U.S. and UK Media]". Berlin. 2019-09-17
BIO Deutschland. (9/17/19). "Pressemittelung: Biotechnologie-Branchenverband wählt neuen Vorstand. 16. Mitgliederversammlung der BIO Deutschland". Berlin. 2019-09-17
Bruker Corporation. (9/16/19). "Press Release: Bruker Announces Release of Breakthrough diaPASEF Workflow for CCS-aware 4D Proteomics on timsTOF Pro Platform at HUPO 2019". Adelaide. 2019-09-16
High-Tech Gründerfonds Management GmbH. (9/16/19). "Press Release: Chemistry-for-Healthcare Start-up Secures Seed Investment from Investitionsbank Berlin (IBB) and High-Tech Gründerfonds (HTGF)". 2019-09-16
Curetis N.V.. (9/16/19). "Press Release: Curetis Group Subsidiary Ares Genetics Signs R&D and Option Agreement with Leading Global IVD Corporation". Holzgerlingen & Vienna. 2019-09-16
MorphoSys AG. (9/16/19). "Press Release: MorphoSys's Licensee Janssen Submits Biologics License Application to U.S. FDA of Tremfya (Guselkumab) for Treatment of Adults with Active Psoriatic Arthritis". Planegg. 2019-09-16
Abionic S.A.. (9/13/19). "Press Release: International Pivotal Study Successfully Demonstrates Diagnosis of Sepsis within 5 Minutes – 24 Hours Earlier Compared with Current Standard-of-Care". Lausanne. 2019-09-13
Max Planck Society. (9/12/19). "Press Release: Launch of Tech Transfer Fund KHAN-I". 2019-09-12
Biocrates Life Sciences AG. (9/12/19). "Press Release: Repositioning of Biocrates – Management Change and New Round of Financing". Innsbruck. 2019-09-12
Inotrem S.A.. (9/12/19). "Press Release: Inotrem Announces €39 Million Series B Financing to Develop First-In-Class Immunology Therapeutics". Paris. 2019-09-12
Max Planck Society. (9/11/19). "Press Release: Max Planck Society Grants License for New Drug Candidates". 2019-09-11
Genedata AG. (9/11/19). "Press Release: Orion Pharmaceuticals Implements Genedata Biologics to Support New Large-Molecule R&D Initiative". Basel. 2019-09-11
Immunexpress, Inc.. (9/11/19). "Press Release: Immunexpress Appoints Jane Papadaki Markley as VP of Market Development and Commercial Operations". Seattle, WA. 2019-09-11
Grünenthal GmbH. (9/10/19). "Press Release: Grünenthal and Mesoblast Enter Strategic Partnership for Europe and Latin America to Develop and Commercialise Innovative Cell Therapy for the Treatment of Chronic Low Back Pain". Aachen & Melbourne. 2019-09-10
ProBioGen AG. (9/10/19). "Press Release: ProBioGen Licenses GlymaxX Technology to Bayer". Berlin. 2019-09-10
ADC Therapeutics S.A.. (9/6/19). "Press Release: ADC Therapeutics Files Registration Statement for Proposed Initial Public Offering". Lausanne. 2019-09-06
Novartis AG. (9/6/19). "Press Release: Novartis Investigational Lung Cancer Therapy Capmatinib (INC280) Granted FDA Breakthrough Therapy Designation for Patients with MET-mutated Advanced Non-small Cell Lung Cancer". Basel. 2019-09-06
iStar Medical S.A.. (9/5/19). "Press Release: iStar Medical Announces EUR 40m Series C Financing". Wavre. 2019-09-05
Evonik Industries AG. (9/5/19). "Press Release: Evonik Invests in Chinese 3D-printing Start-up Making Medical Implants". Essen & Shanghai. 2019-09-05
Abionic S.A.. (9/5/19). "Press Release: Abionic Signs Agreement to Optimize Asthma Management in the U.S. through Innovative Rapid Point-of-Care Tests". Lausanne. 2019-09-05
Curetis N.V.. (9/4/19). "Press Release: Curetis and OpGen Enter Into Definitive Agreement to Combine Businesses". Gaithersburg, MD, Amsterdam & Holzgerlingen. 2019-09-04
AC Immune S.A.. (9/4/19). "Press Release: AC Immune Awarded Michael J. Fox Foundation Grant to Accelerate Development of Parkinson’s Disease Diagnostic Imaging Agent". Lausanne. 2019-09-04
Boehringer Ingelheim. (9/4/19). "Press Release: Boehringer Ingelheim Expands KRAS Cancer Program with Lupin’s Clinical Stage MEK Inhibitor Compound". Ingelheim & Mumbai. 2019-09-04
Modag GmbH. (9/4/19). "Press Release: Modag Appoints Dr. Johannes Levin as Chief Medical Officer". Wendelsheim. 2019-09-04
BioNTech SE. (9/4/19). "Press Release: BioNTech Announces New Collaboration to Develop HIV and Tuberculosis Programs". Mainz. 2019-09-04
Fulcrum Therapeutics, Inc.. (9/4/19). "Press Release: Fulcrum Therapeutics Appoints Pamela Strode, Seasoned Industry Executive, to Lead Regulatory Affairs Team". Cambridge, MA. 2019-09-04
Evonik Industries AG. (9/3/19). "Press Release: Evonik Acquires a Surface Modification Technology Platform from Interface Biologics to Further Expand Its Medical Device Capabilities". 2019-09-03
Novartis AG. (9/3/19). "Press Release: Sandoz Announces Global Deal to Commercialize Proposed Biosimilar Natalizumab, a Key Multiple Sclerosis Medicine". Holzkirchen. 2019-09-03
Agilent Technologies Inc.. (9/3/19). "Press Release: Agilent Collaborates on Groundbreaking Study of Performance-Enhancing Spinach Extract". Santa Clara, CA. 2019-09-03
Roche. (9/3/19). "Press Release: Roche and Spark Therapeutics, Inc. Announce Extension of Tender Offer for Shares of Spark Therapeutics, Inc.". Basel. 2019-09-03
Grünenthal GmbH. (9/3/19). "Press Release: Grünenthal and UniQuest Partner to Develop Novel Drug Candidates for Chronic Neuropathic Pain". Aachen & Brisbane. 2019-09-03
Boehringer Ingelheim. (9/3/19). "Press Release: Boehringer Ingelheim and Zealand Pharma Advance Dual-Acting GLP-1/Glucagon Agonist BI 456906 to Phase 2 Clinical Testing in Obesity/Diabetes". Ingelheim & Copenhagen. 2019-09-03
Bruker Corporation. (9/2/19). "Press Release: Bruker Launches Highest Resolution Large-Format Bio-AFM System". Münster. 2019-09-02
Lunaphore Technologies S.A.. (8/30/19). "Press Release: Lunaphore Appoints Joseph Bernardo as New Chairman of the Board". Lausanne. 2019-08-30
Orbit Discovery Ltd.. (8/30/19). "Press Release: Mario Polywka Joins Orbit Discovery’s Board of Directors". Oxford. 2019-08-30
Tecan Group Ltd.. (8/30/19). "Press Release: Tania Micki to Succeed Long-time CFO Rudolf Eugster in Q1 2020 with effect from 2019 Annual Financial Statements". Männedorf. 2019-08-30
Novartis AG. (8/30/19). "Press Release: Novartis Ofatumumab Demonstrates Superiority versus Aubagio in Two Head-to-head Phase III Multiple Sclerosis Studies". Basel. 2019-08-30
Roche. (8/29/19). "Press Release: European Commission Approves Roche’s Tecentriq in Combination with Abraxane for People with PD-L1-positive, Metastatic Triple-negative Breast Cancer". Basel. 2019-08-29
Vivoryon Therapeutics AG. (8/29/19). "Press Release: Vivoryon Therapeutics Reports Financial Results for H1 2019 and Corporate Update". Halle (Saale). 2019-08-29
Roche. (8/29/19). "Press Release: Roche Launches Ventana PD-L1 (SP142) Assay in CE Markets as First Companion Diagnostic to Identify Triple-negative Breast Cancer Patients Eligible for Treatment with Tecentriq". Basel. 2019-08-29
Adrenomed AG. (8/29/19). "Press Release: Adrenomed Supervisory Board Appoints Jens Schneider-Mergener as CEO and Jens Zimmermann, CMO, Joins the Executive Board". Hennigsdorf. 2019-08-29
Immatics Biotechnologies GmbH. (8/28/19). "Press Release: Immatics and Celgene Enter Strategic Collaboration to Develop Novel Adoptive Cell Therapies". Houston, TX & Tübingen. 2019-08-28
IBB Beteiligungsgesellschaft mbH. (8/27/19). "Pressemitteilung: Berliner Startup Krankenhaus.de sammelt Seed-Runde ein". 2019-08-27
Bruker Corporation. (8/26/19). "Press Release: Bruker Announces World's First 1.2 GHz High-Resolution Protein NMR Data". Berlin. 2019-08-26
ADC Therapeutics S.A.. (8/26/19). "Press Release: ADC Therapeutics and Freenome Enter Biomarker Development Collaboration". Lausanne & South San Francisco, CA. 2019-08-26
Bruker Corporation. (8/25/19). "Press Release: Bruker Introduces Next-Generation 80 MHz Benchtop FT-NMR System". Berlin. 2019-08-25
Idorsia Ltd.. (8/23/19). "Press Release: Clinical Data on Idorsia’s Pipeline Compounds Will Be Presented at the European Society of Cardiology Congress 2019". Allschwil. 2019-08-23
Themis Bioscience GmbH. (8/22/19). "Press Release: Themis Bioscience Announces Exclusive License and Research Collaboration Agreement with MSD to Develop Vaccine Candidates". Vienna. 2019-08-22
PerkinElmer, Inc.. (8/21/19). "Press Release: PerkinElmer Announces Leadership Succession Plan". Waltham, MA. 2019-08-21
Oncorus, Inc.. (8/21/19). "Press Release: Oncorus Announces $79.5 Million Series B Financing Co-Led by Cowen Healthcare Investments and Perceptive Advisors". Cambridge, MA. 2019-08-21
Cytosurge AG. (8/21/19). "Press Release: Cytosurge AG Announces Spin-off of Its 3D Printing Business Unit". Glattbrugg. 2019-08-21
Bayer AG. (8/20/19). "Press Release: Bayer to Sell Its Animal Health Business Unit to Elanco for 7.6 Billion U.S. Dollars". Leverkusen. 2019-08-20
Araris Biotech AG. (8/20/19). "Press Release: Araris Biotech AG Closes Seed Financing Round of CHF 2.5 Million". Zurich. 2019-08-20
Eppendorf AG. (8/20/19). "Press Release: Eppendorf AG with Positive First Half-year 2019. Group Sales Grow by 12.8% Percent to €378.5 million". Hamburg. 2019-08-20
Genentech, Inc.. (8/19/19). "Press Release: Retirement of Dr. Sandra Horning & Appointment of Dr. Levi Garraway to Chief Medical Officer, Roche and Genentech". South San Francisco, CA. 2019-08-19
Nabriva Therapeutics plc. (8/19/19). "Press Release: Nabriva Therapeutics Receives U.S. FDA Approval of Xenleta (lefamulin) to Treat Community-Acquired Bacteria Pneumonia (CABP)". Dublin. 2019-08-19
Nabriva Therapeutics plc. (8/16/19). "Press Release: Nabriva Therapeutics Provides Update on the Planned Resubmission of the New Drug Application for Intravenous Contepo (fosfomycin) for Injection". Dublin. 2019-08-16
Roche. (8/16/19). "Press Release: FDA Approves Roche’s Rozlytrek (entrectinib) for People with ROS1-positive, MMetastatic Non-small Cell Lung Cancer and NTRK Gene Fusion-positive Solid Tumours". Basel. 2019-08-16
Tecan Group Ltd.. (8/15/19). "Press Release: H1 2019 – Tecan Again Posts Significant Increase in Sales, Driven by Strong Growth in the Life Sciences Business". Männedorf. 2019-08-15
H. Lundbeck A/S. (8/14/19). "Press Release: Lundbeck Appoints New EVP, People & Communication". Valby. 2019-08-14
Grünenthal GmbH. (8/13/19). "Pressemitteilung: Einigung über Neuausrichtung der Forschungs- und Entwicklungsorganisation bei Grünenthal". Aachen. 2019-08-13
Pharming Group N.V.. (8/13/19). "Press Release: Pharming Acquires Exclusive License to CDZ173, a Late Stage Drug for the Treatment of APDS". Leiden. 2019-08-13
Nynomic AG. (8/12/19). "Press Release: Acquisition of the Business Operations of LemnaTec GmbH Strengthens Technological Competence in the Field of Plant Phenotyping". Wedel. 2019-08-12
GlaxoSmithKline plc. (8/12/19). "Press Release: GSK Announces Leadership Changes in the US". Philadeliphia, PA. 2019-08-12
Boehringer Ingelheim. (8/12/19). "Press Release: Boehringer Ingelheim and MD Anderson Form Unique Virtual Research and Development Center to Rapidly Advance New Cancer Therapies". Ingelheim. 2019-08-12
Curetis N.V.. (8/12/19). "Press Release: Curetis Retains H.C. Wainwright & Co. as Strategic Advisor". Amsterdam & Holzgerlingen. 2019-08-12
AC Immune S.A.. (8/12/19). "Press Release: AC Immune Announces Research Collaboration with University of Pennsylvania Focusing on Pathogenic Protein TDP-43 in Neurodegenerative Diseases". Lausanne. 2019-08-12
Boehringer Ingelheim. (8/12/19). "Press Release: Boehringer Ingelheim Opens Health Management Centre in China". Shanghai. 2019-08-12
High-Tech Gründerfonds Management GmbH. (8/8/19). "Press Release: Successful Exit for High-Tech Gründerfonds (HTGF) – HTGF sells Its Cytena Shares to Cellink in a Trade Sale". 2019-08-08
BlueRock Therapeutics. (8/8/19). "Press Release: Bayer Acquires BlueRock Therapeutics to Build Leading Position in Cell Therapy". Berlin & Cambridge, MA. 2019-08-08
Curetis N.V.. (8/8/19). "Press Release: Curetis Group Company Ares Genetics Launches Service Laboratory for NGS-based Molecular Drug Resistance Testing". Vienna & Holzgerlingen. 2019-08-08
IMBA – Institute of Molecular Biotechnology GmbH. (8/7/19). "Press Release: a:head bio – Launched to Transform CNS Drug Discovery". 2019-08-07
NMI TT Pharmaservices. (8/6/19). "Press Release: LI-COR Biosciences Introduces DigiWest to Accelerate Targeted Therapeutics Development". Lincoln, NE. 2019-08-06
Expedeon AG. (8/6/19). "Press Release: Expedeon AG Signs Commercial Agreement with Sona Nanotech". Halifax, Heidelberg & Cambridge. 2019-08-06
Merck KGaA. (8/6/19). "Press Release: Merck Acquires BSSN Software to Accelerate Customers’ Digital Transformation in the Lab". Darmstadt. 2019-08-06
IBB Beteiligungsgesellschaft mbH. (8/6/19). "Press Release: Million-euro Financing for Berlin-based Start-up Mika ". Berlin. 2019-08-06
Platomics GmbH. (8/6/19). "Press Release: 7-digit Investment in Future Technology Genetic Testing". 2019-08-06
ADC Therapeutics S.A.. (8/6/19). "Press Release: ADC Therapeutics and Sophia Genetics Partner for Biomarker Discovery in Pivotal Phase II Clinical Trial". Lausanne. 2019-08-06
Mologen AG. (8/5/19). "Press Release: Mologen AG Announces Top Line Data of Pivotal IMPALA Study in Metastatic Colorectal Cancer. Primary Endpoint Not Met". Berlin. 2019-08-05
Cytena GmbH. (8/5/19). "Press Release: Cytena GmbH Announces that It Has Been Entered into an Agreement to Be Acquired by Cellink". Freiburg. 2019-08-05
Imcyse. (8/5/19). "Press Release: Imcyse Announces Changes in Management and Board, Appoints Thomas Taapken as Executive Chairman". Liège. 2019-08-05
Inveox GmbH. (8/5/19). "Press Release: 17 Million for Future Cancer Diagnoses. Inveox Acquires Further Investment". Munich. 2019-08-05
Roche. (8/5/19). "Press Release: Roche’s Tecentriq plus Platinum-based Chemotherapy Reduced the Risk of Disease Worsening or Death in People with Previously Untreated Advanced Bladder Cancer". Basel. 2019-08-05
GNA Biosolutions GmbH. (8/5/19). "Press Release: GNA Biosolutions Closes $13.5M Series C Financing Round Backed by a US/EU consortium". Munich. 2019-08-05
ExpreS2ion Biotech Holding AB. (8/2/19). "Press Release: ExpreS2ion’s Licensee Institut Virion\Serion Launches the First in Vitro Diagnostic Product Based on the ExpreS2-platform". 2019-08-02
Pieris Pharmaceuticals, Inc.. (8/1/19). "Press Release: Pieris Pharmaceuticals Appoints Dr. Maya Said to its Board of Directors". Boston, MA. 2019-08-01
Pieris Pharmaceuticals, Inc.. (8/1/19). "Press Release: Pieris Pharmaceuticals Reports Second Quarter 2019 Cash Position and Provides Corporate Update". Boston, MA. 2019-08-01
Bruker Corporation. (8/1/19). "Press Release: Bruker Reports Second Quarter 2019 Financial Results". Billerica, MA. 2019-08-01
Curetis N.V.. (8/1/19). "Press Release: Curetis Elects Share Settlement for Excess Entitlement Under First Tranche of Yorkville Convertible Notes". Amsterdam, San Diego, CA & Holzgerlingen. 2019-08-01
Thrive Earlier Detection Corporation. (8/1/19). "Press Release: Thrive Earlier Detection Announces Appointment of David J. Daly as Chief Executive Officer". Cambridge, MA. 2019-08-01
Sensyne Health plc. (7/31/19). "Press Release: Sensyne Health Signs Collaboration Agreement with Bayer to Accelerate the Development of New Treatments for Cardiovascular Disease Using Clinical Artificial Intelligence". 2019-07-31
Sirion Biotech GmbH. (7/31/19). "Press Release: Gene and Cell Therapy Solutions Provider, Sirion Biotech Announces Record First Half 2019 Financial Results". Munich. 2019-07-31
Wellington Partners. (7/31/19). "Press Release: Wellington Partners Raises EUR 210 Million Life Science Fund". 2019-07-31
Bayer AG. (7/31/19). "Press Release: U.S. FDA Approves Darolutamide, a New Treatment for Men with Non-metastatic Castration-resistant Prostate Cancer [Not intended for U.S. and UK Media]". Berlin. 2019-07-31
Curetis N.V.. (7/30/19). "Press Release: Curetis and Ako Med Ink Distribution Agreement Covering Four Countries in CEE Region". Amsterdam, San Diego, CA & Holzgerlingen. 2019-07-30
next pagenext page 1 2 3 ... 97 98 99  next pagenext page



Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px

» top